Publications Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn’s Disease Citation George J, Singh S, Dulai PS, Ma C, Nguyen T, Feagan BG, Sandborn WJ, Jairath V. Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease. Inflamm Bowel Dis. 2020 Mar 4;26(4):515-523. doi: 10.1093/ibd/izz193. PMID: 31504528; PMCID: PMC8127062. Abstract Background: We summarized the protocol-specified corticosteroid tapering regimens in clinical trials of moderate-severe ulcerative colitis (UC) and Crohn’s disease (CD) and calculated differences in rates of clinical remission vs corticosteroid-free clinical remission (CSF-CR). Tags Adrenal Cortex Hormones, Biological Products, Clinical Trials, Crohn's Disease, Drug Therapy, End Points, Maintenance Therapy, therapeutic use, Ulcerative Colitis Read More
